These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9607389)

  • 1. Insulin receptor number in arterial hypertension: response to treatment with fosinopril or atenolol.
    Makris T; Krespi P; Triposkiadis F; Votteas V; Hatzizaharias A; Kyriakidis M
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):494-6. PubMed ID: 9607389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal muscle angiotensin-converting enzyme and its relationship to blood pressure in primary hypertension and healthy elderly men.
    Reneland R; Haenni A; Andersson PE; Andrén B; Lithell H
    Blood Press; 1999; 8(1):16-22. PubMed ID: 10412878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition.
    Reneland R; Andersson PE; Haenni A; Lithell H
    Eur J Clin Pharmacol; 1994; 46(5):431-6. PubMed ID: 7957538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T; Lehtonen A
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertension combined with atherosclerotic lesions in carotid arteries: should angiotensin converting enzyme inhibitors be prescribed?].
    Fomin VV; Moiseev SV
    Kardiologiia; 2005; 45(12):99-102. PubMed ID: 16353055
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of fosinopril on progression of the asymptomatic carotid atherosclerosis and left ventricular hypertrophy in hypertensive patients].
    Tasić IS; Mijalković D; Djordjević D; Lović B; Janković D; Miladinović-Tasić N; Lović M
    Srp Arh Celok Lek; 2006; 134(3-4):106-13. PubMed ID: 16915750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients.
    Savoia C; Touyz RM; Endemann DH; Pu Q; Ko EA; De Ciuceis C; Schiffrin EL
    Hypertension; 2006 Aug; 48(2):271-7. PubMed ID: 16785331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of fosinopril/hydrochlorothiazide combinations on ambulatory blood pressure profiles in hypertension. Fosinopril/Hydrochlorothiazide Investigators.
    Guthrie R; Reggi DR; Plesher MM; Saini RK; Battikha JP
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):306-11. PubMed ID: 8722432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin sensitivity in obese hypertensive dyslipidemic patients treated with enalapril or atenolol.
    Morel Y; Gadient A; Keller U; Vadas L; Golay A
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):306-11. PubMed ID: 7475056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of insulin resistance by beta-blockade but not ACE-inhibition: long-term treatment with atenolol or trandolapril.
    Reneland R; Alvarez E; Andersson PE; Haenni A; Byberg L; Lithell H
    J Hum Hypertens; 2000 Mar; 14(3):175-80. PubMed ID: 10694831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of hypertension in the elderly: Fosinopril in Old Patients Study (FOPS)].
    Koch J; Greminger P; Simeon-Dubach D
    Praxis (Bern 1994); 1997 Nov; 86(45):1779-84. PubMed ID: 9446181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or beta-blockade in patients with essential hypertension.
    Buus NH; Bøttcher M; Jørgensen CG; Christensen KL; Thygesen K; Nielsen TT; Mulvany MJ
    Hypertension; 2004 Oct; 44(4):465-70. PubMed ID: 15326083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor index: a novel method for measuring pharmacological inhibition of angiotensin-converting enzyme.
    Reneland R; Lithell H
    Blood Press; 1997 Mar; 6(2):103-8. PubMed ID: 9105649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity].
    Rosolová H; Cech J; Sefrna F
    Vnitr Lek; 2001 Dec; 47(12):834-9. PubMed ID: 11826546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the antihypertensive activity of fosinopril and irbesartan].
    Angulo E; Robles NR; Grois J; Barquero A; Pérez Miranda M
    An Med Interna; 2002 Nov; 19(11):571-5. PubMed ID: 12522893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atenolol vs enalapril in young hypertensive patients after successful repair of aortic coarctation.
    Di Salvo G; Castaldi B; Gala S; Baldini L; Del Gaizo F; D'Aiello FA; Mormile A; Rea A; Scognamiglio G; Pacileo G; Keating S; Fadel BM; Berrino L; Perna A; Russo MG; Calabrò R
    J Hum Hypertens; 2016 Jun; 30(6):363-7. PubMed ID: 26290275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the combination of enalapril and a very low dose of hydrochlorothiazide with atenolol in patients with mild-to-moderate hypertension. Scandinavian Study Group.
    Os I; Hotnes T; Dollerup J; Mogensen CE
    Am J Hypertens; 1997 Aug; 10(8):899-904. PubMed ID: 9270085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Losartan vs atenolol in prevention of stroke and cardiovascular disease.
    Fournier A; Oprisiu R; Andrejak M; Fernandez L; Achard JM
    JAMA; 2003 Feb; 289(6):700; author reply 701. PubMed ID: 12585946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.